By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Omeros Corporation 

1420 Fifth Avenue
Suite 2675
Seattle  Washington  98101  U.S.A.
Phone: 206-623-4688 Fax: 206-264-7856



Company News
Omeros Corporation (OMER) Files Infringement Suits Against Par Pharmaceutical Companies (PRX) 9/3/2015 8:28:24 AM
Omeros Corporation (OMER) Announces Additional Positive Data In OMS721 Phase 2 Clinical Trial 8/18/2015 6:16:47 AM
Omeros Corporation (OMER) Announces Plan To File Infringement Suit Against ANDA Filer 8/17/2015 6:11:34 AM
Omeros Corporation (OMER) Reports Second Quarter 2015 Financial Results 8/11/2015 10:19:19 AM
Omeros Corporation (OMER) To Present At The 2015 Wedbush PacGrow Healthcare Conference 8/7/2015 6:44:23 AM
Omeros Corporation (OMER) To Announce Second Quarter 2015 Financial Results On August 10, 2015 8/3/2015 7:35:18 AM
Omeros Corporation (OMER) Release: Omidria Approved For Commercialization Throughout The European Union And Additional Countries 8/3/2015 6:44:41 AM
FDA Grants "Fast Track" To Omeros Corporation (OMER)' Complement Inhibitor OMS721 For aHUS 7/23/2015 9:00:19 AM
Rajiv Shah, M.D., Appointed To Omeros Corporation (OMER)' Board Of Directors 6/17/2015 8:43:37 AM
Omeros Corporation (OMER)Announces Exclusive License Agreement For Omeros' Arthroscopic Product OMS103 6/16/2015 6:11:07 AM